Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1005)	9/23/1998 9:13:00 PM
From: Highway Jim	Read Replies (1) \| Respond to of 1580

Where is every one!!!

To: Anthony Wong who wrote (1005)	11/5/1998 4:35:00 PM
From: Elmer Flugum	Read Replies (2) \| Respond to of 1580

~~All responses to this question to be addressed to cocktailtime@yahoo.com Are Merck shareholders aware of the action of the drugs, Lovastatin/Onconase, against cancer. Lovastatin is owned by Merck, FDA approved to treat high cholesterol, but also shows synergism with another drug called Onconase, owned by a company called Alfacell. Together, the drugs are very powerful against cancer. Alfacell is pursuing Onconase alone, their clinical trials have failed, and they're going broke fast. They have not pursued and are unlikely to pursue the powerful synergistic affects of Lovastatin/Onconase, if only because all the money will soon be gone and/Merck owns Lovastatin, and their shareholders are simply watching the clock tick, while cancer sufferers are being deprived of a real opportunity for help in areas of cancer where there is currently no effective treatment. There is great potential if Merck could grab this "diamond in the rough", and bring this baby home. There's great, great potential this would make the world look at protease inhibitors (the latest things against AIDS) as old fashion medicine, and leave the other large biotech companies scratching their heads, saying, "how did we miss this one?" Merck knows as well as anyone that we live in an era of drug cocktails (it takes 3 to 4 drugs at a time to be effective against AIDS, among them Merck's, in combination they seem to knock the hell out of it). Why does Merck seem to be missing this regarding Lovastatin/Onconase? And what can be done to get them on it?